← DiscoverAI PREDICTION · 3-MONTH VIEW
SR
SRRK
XNASScholar Rock Holding Corporation
Mkt Cap $5.7BBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FUNDAMENTALS
EV/EBITDA
-15.22P/B
23.35EPS (TTM)
$-3.41ROE
-148.1%ROA
-76.4%FCF
$-303.9MMKT CAP
$6.4BTECHNICAL ANALYSIS
Mixed
RSI-14
52.0
Neutral
MACD
2.516
Bearish
SMA-50
$-1.00
$-1.00
SMA-200
$-1.00
$-1.00
BOLL %B
0.56
Within bands
ATR-14
$2.27
RVOL
0.30x
Low activity
MOMENTUM
-3.6%
10d -1.7% / 30d +14.0%
●In line with the market
SRRK ranks stronger over the next month than over 3 months.
WHERE IT RANKS · vs 2,129 names
20-DAY
▲Top 9%#192
60-DAY
●Bottom 33%#1421
TYPICAL 3-MO RANGE · vs S&P 500
+0.1%no clear edge+1.1%
▸ Horizon detail
20dTop 9%
60dBottom 33%
1y+analyst mean$60.72+12.2%
⚡ AI INSIGHT
Our model reads SRRK as strong near-term but middling over the next few months. Analysts stay bullish (96% Buy), so the softer outlook reads more like a pause than a problem.
ANALYST CONSENSUS
96% Buy
23 Buy1 Hold0 Sell
Low
$48
Mean
$61
High
$74
SHORT & FLOAT
Free Float
77.3%
9.6 days to cover.